共 216 条
[1]
Lee HJ(2006)Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies Autoimmunity 39 433-444
[2]
Sinha AA(1981)Distinctive cutaneous subsets in the spectrum of lupus erythematosus J Am Acad Dermatol 4 471-475
[3]
Gilliam JN(2001)The cutaneous pathology of lupus erythematosus: a review J Cutan Pathol 28 1-23
[4]
Sontheimer RD(2011)Cutaneous lupus erythematosus: update of therapeutic options Part I J Am Acad Dermatol 65 e179-193
[5]
Crowson AN(2005)Management of 'refractory' skin disease in patients with lupus erythematosus Best Pract Res Clin Rheumatol 19 767-784
[6]
Magro C(2011)Cutaneous lupus erythematosus: update of therapeutic options Part II J Am Acad Dermatol 65 e195-213
[7]
Kuhn A(1962)The saga of thalidomide. Neuropathy to embriopathy, with case reports of congenital abnormalities N Engl J Med 267 1184-1192
[8]
Ruland V(2005)Thalidomide: dermatological indications, mechanisms of action and side-effects Br J Dermatol 153 254-273
[9]
Bonsmann G(2003)Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus Arch Dermatol 139 50-54
[10]
Callen JP(2000)Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus Int J Dermatol 39 218-222